keyword
https://read.qxmd.com/read/38483896/jun-mrna-translation-regulation-is-mediated-by-multiple-5-utr-and-start-codon-features
#1
JOURNAL ARTICLE
Angélica M González-Sánchez, Eimy A Castellanos-Silva, Gabriela Díaz-Figueroa, Jamie H D Cate
Regulation of mRNA translation by eukaryotic initiation factors (eIFs) is crucial for cell survival. In humans, eIF3 stimulates translation of the JUN mRNA which encodes the transcription factor JUN, an oncogenic transcription factor involved in cell cycle progression, apoptosis, and cell proliferation. Previous studies revealed that eIF3 activates translation of the JUN mRNA by interacting with a stem loop in the 5' untranslated region (5' UTR) and with the 5' -7-methylguanosine cap structure. In addition to its interaction site with eIF3, the JUN 5' UTR is nearly one kilobase in length, and has a high degree of secondary structure, high GC content, and an upstream start codon (uAUG)...
2024: PloS One
https://read.qxmd.com/read/38234533/retracted-rocaglamide-prolonged-allograft-survival-by-inhibiting-differentiation-of-th1-th17-cells-in-cardiac-transplantation
#2
Oxidative Medicine And Cellular Longevity
[This retracts the article DOI: 10.1155/2022/2048095.].
2024: Oxidative Medicine and Cellular Longevity
https://read.qxmd.com/read/38014201/-jun-mrna-translation-regulation-is-mediated-by-multiple-5-utr-and-start-codon-features
#3
Angélica M González-Sánchez, Eimy A Castellanos-Silva, Gabriela Díaz-Figueroa, Jamie H D Cate
Regulation of mRNA translation by eukaryotic initiation factors (eIFs) is crucial for cell survival. In humans, eIF3 stimulates translation of the JUN mRNA which encodes the transcription factor JUN, an oncogenic transcription factor involved in cell cycle progression, apoptosis, and cell proliferation. Previous studies revealed that eIF3 activates translation of the JUN mRNA by interacting with a stem loop in the 5' untranslated region (5' UTR) and with the 5' -7-methylguanosine cap structure. In addition to its interaction site with eIF3, the JUN 5' UTR is nearly one kilobase in length, and has a high degree of secondary structure, high GC content, and an upstream start codon (uAUG)...
November 17, 2023: bioRxiv
https://read.qxmd.com/read/37088154/characterization-of-plasmodium-falciparum-prohibitins-as-novel-targets-to-block-infection-in-humans-by-impairing-the-growth-and-transmission-of-the-parasite
#4
JOURNAL ARTICLE
Monika Saini, Che Julius Ngwa, Manisha Marothia, Pritee Verma, Shakeel Ahmad, Jyoti Kumari, Sakshi Anand, Vandana Vandana, Bharti Goyal, Soumyananda Chakraborti, Kailash C Pandey, Swati Garg, Soumya Pati, Anand Ranganathan, Gabriele Pradel, Shailja Singh
Prohibitins (PHBs) are highly conserved pleiotropic proteins as they have been shown to mediate key cellular functions. Here, we characterize PHBs encoding putative genes of Plasmodium falciparum by exploiting different orthologous models. We demonstrated that PfPHB1 (PF3D7_0829200) and PfPHB2 (PF3D7_1014700) are expressed in asexual and sexual blood stages of the parasite. Immunostaining indicated these proteins as mitochondrial residents as they were found to be localized as branched structures. We further validated PfPHBs as organellar proteins residing in Plasmodium mitochondria, where they interact with each other...
April 21, 2023: Biochemical Pharmacology
https://read.qxmd.com/read/36780842/mitomycin-c-enhanced-the-antitumor-efficacy-of-rocaglamide-in-colorectal-cancer
#5
JOURNAL ARTICLE
Liguo Xie, Lifangyu Cheng, Yunlin Wei
Rocaglamide (ROC), a natural phytochemical isolated from Aglaia species, is a translational inhibitor of de novo c-FLIP synthesis, which relieves the inhibition of c-FLIP dimerization with procasoase-8 and downstream activation. Unfortunately, a lot of cancer cells, especially colorectal cancer cells (CRC), exhibit marked resistance to Rocaglamide-induced cell death. Research has demonstrated that mitomycin C (MMC) has broad-spectrum anti-tumor activity that it can synergize with a wide range of clinical drugs to inhibit tumor growth...
February 4, 2023: Pathology, Research and Practice
https://read.qxmd.com/read/36725859/reanalysis-of-ribosome-profiling-datasets-reveals-a-function-of-rocaglamide-a-in-perturbing-the-dynamics-of-translation-elongation-via-eif4a
#6
JOURNAL ARTICLE
Fajin Li, Jianhuo Fang, Yifan Yu, Sijia Hao, Qin Zou, Qinglin Zeng, Xuerui Yang
The quickly accumulating ribosome profiling data is an insightful resource for studying the critical details of translation regulation under various biological contexts. Rocaglamide A (RocA), an antitumor heterotricyclic natural compound, has been shown to inhibit translation initiation of a large group of mRNA species by clamping eIF4A onto poly-purine motifs in the 5' UTRs. However, reanalysis of previous ribosome profiling datasets reveals an unexpected shift of the ribosome occupancy pattern, upon RocA treatment in various types of cells, during early translation elongation for a specific group of mRNA transcripts without poly-purine motifs over-represented in their 5' UTRs...
February 2, 2023: Nature Communications
https://read.qxmd.com/read/36598533/regulatory-t-cells-suppress-cd4-effector-t-cell-activation-by-controlling-protein-synthesis
#7
JOURNAL ARTICLE
Lomon So, Kazushige Obata-Ninomiya, Alex Hu, Virginia S Muir, Ayako Takamori, Jing Song, Jane H Buckner, Ram Savan, Steven F Ziegler
Regulatory T cells (Tregs) suppress the activation and subsequent effector functions of CD4 effector T cells (Teffs). However, molecular mechanisms that enforce Treg-mediated suppression in CD4 Teff are unclear. We found that Tregs suppressed activation-induced global protein synthesis in CD4 Teffs prior to cell division. We analyzed genome-wide changes in the transcriptome and translatome of activated CD4 Teffs. We show that mRNAs encoding for the protein synthesis machinery are regulated at the level of translation in activated CD4 Teffs by Tregs...
March 6, 2023: Journal of Experimental Medicine
https://read.qxmd.com/read/36144626/enzymatic-and-molecular-characterization-of-anti-leishmania-molecules-that-differently-target-leishmania-and-mammalian-eif4a-proteins-lieif4a-and-eif4a-mus
#8
JOURNAL ARTICLE
Yosser Zina Abdelkrim, Emna Harigua-Souiai, Imen Bassoumi-Jamoussi, Mourad Barhoumi, Josette Banroques, Khadija Essafi-Benkhadir, Michael Nilges, Arnaud Blondel, N Kyle Tanner, Ikram Guizani
Previous investigations of the Leishmania infantum eIF4A-like protein (LieIF4A) as a potential drug target delivered cholestanol derivatives inhibitors. Here, we investigated the mode of action of cholesterol derivatives as a novel scaffold structure of LieIF4A inhibitors on the RNA-dependent ATPase activity of LieIF4A and its mammalian ortholog (eIF4AI). We compared their biochemical effects on RNA-dependent ATPase activities of both proteins and investigated if rocaglamide, a known inhibitor of eIF4A, could affect LieIF4A as well...
September 10, 2022: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/36109625/in-silico-study-on-the-hepatitis-e-virus-rna-helicase-and-its-inhibition-by-silvestrol-rocaglamide-and-other-flavagline-compounds
#9
JOURNAL ARTICLE
Lorenzo Pedroni, Luca Dellafiora, Maria Olga Varrà, Gianni Galaverna, Sergio Ghidini
Hepatitis E Virus (HEV) follows waterborne or zoonotic/foodborne transmission. Genotype 3 HEV infections are worldwide spread, especially in swine populations, representing an emerging threat for human health, both for farm workers and pork meat consumers. Unfortunately, HEV in vitro culture and analysis are still difficult, resulting in a poor understanding of its biology and hampering the implementation of counteracting strategies. Indeed, HEV encodes for only one non-structural multifunctional and multidomain protein (ORF1), which might be a good candidate for anti-HEV drugging strategies...
September 15, 2022: Scientific Reports
https://read.qxmd.com/read/36058921/novel-eif4a1-inhibitors-with-anti-tumor-activity-in-lymphoma
#10
JOURNAL ARTICLE
Forum Kayastha, Noah B Herrington, Bandish Kapadia, Anirban Roychowdhury, Nahid Nanaji, Glen E Kellogg, Ronald B Gartenhaus
BACKGROUND: Deregulated translation initiation is implicated extensively in cancer initiation and progression. It is actively pursued as a viable target that circumvents the dependency on oncogenic signaling, a significant factor in current strategies. Eukaryotic translation initiation factor (eIF) 4A plays an essential role in translation initiation by unwinding the secondary structure of messenger RNA (mRNA) upstream of the start codon, enabling active ribosomal recruitment on the downstream genes...
September 4, 2022: Molecular Medicine
https://read.qxmd.com/read/35720115/hierarchical-virtual-screening-based-on-rocaglamide-derivatives-to-discover-new-potential-anti-skin-cancer-agents
#11
JOURNAL ARTICLE
Igor V F Dos Santos, Rosivaldo S Borges, Guilherme M Silva, Lúcio R de Lima, Ruan S Bastos, Ryan S Ramos, Luciane B Silva, Carlos H T P da Silva, Cleydson B R Dos Santos
Skin Cancer (SC) is among the most common type of cancers worldwide. The search for SC therapeutics using molecular modeling strategies as well as considering natural plant-derived products seems to be a promising strategy. The phytochemical Rocaglamide A (Roc-A) and its derivatives rise as an interesting set of reference compounds due to their in vitro cytotoxic activity with SC cell lines. In view of this, we performed a hierarchical virtual screening study considering Roc-A and its derivatives, with the aim to find new chemical entities with potential activity against SC...
2022: Frontiers in Molecular Biosciences
https://read.qxmd.com/read/35087613/rocaglamide-prolonged-allograft-survival-by-inhibiting-differentiation-of-th1-th17-cells-in-cardiac-transplantation
#12
JOURNAL ARTICLE
Chen Dai, Xi Zhou, Lu Wang, Rumeng Tan, Wei Wang, Bo Yang, Yucong Zhang, Huibo Shi, Dong Chen, Lai Wei, Zhishui Chen
Background: Aglaia (Meliaceae) species are used for treating autoimmune disorders and allergic diseases in Asian countries. Rocaglamide, an extract obtained from Aglaia species, exhibits suppressive effect by regulating the T cell subset balance and cytokine network in cancer. However, whether it can be used in organ transplantation is unknown. In this study, we investigated the antirejection effect and mechanism of action of rocaglamide in a mouse cardiac allograft model. Methods: Survival studies were performed by administering mice with phosphate-buffered saline (PBS) ( n = 6) and rocaglamide ( n = 8)...
2022: Oxidative Medicine and Cellular Longevity
https://read.qxmd.com/read/35002511/rocaglamide-promotes-the-infiltration-and-antitumor-immunity-of-nk-cells-by-activating-cgas-sting-signaling-in-non-small-cell-lung-cancer
#13
JOURNAL ARTICLE
Xuewei Yan, Chao Yao, Cheng Fang, Min Han, Chenyuan Gong, Dan Hu, Weiming Shen, Lixin Wang, Suyun Li, Shiguo Zhu
Background: Natural killer (NK) cell-based immunotherapy is clinically limited due to insufficient tumor infiltration in solid tumors. We have previously found that the natural product rocaglamide (RocA) can enhance NK cell-mediated killing of non-small cell lung cancer (NSCLC) cells by inhibiting autophagy, and autophagic inhibition has been shown to increase NK cell tumor infiltration in melanoma. Therefore, we hypothesized that RocA could increase NK cell infiltration in NSCLC by autophagy inhibition. Methods: Flow cytometry, RNA-sequencing, real-time PCR, Western blotting analysis, and xenograft tumor model were utilized to assess the infiltration of NK cells and the underlying mechanism...
2022: International Journal of Biological Sciences
https://read.qxmd.com/read/34906136/targeted-intervention-of-eif4a1-inhibits-emt-and-metastasis-of-pancreatic-cancer-cells-via-c-myc-mir-9-signaling
#14
JOURNAL ARTICLE
Yuchong Zhao, Yun Wang, Wei Chen, Shuya Bai, Wang Peng, Mengli Zheng, Yilei Yang, Bin Cheng, Zhou Luan
BACKGROUND: Owing to the lack of effective treatment options, early metastasis remains the major cause of pancreatic ductal adenocarcinoma (PDAC) recurrence and mortality. However, the molecular mechanism of early metastasis is largely unknown. We characterized the function of eukaryotic translation initiation factors (eIFs) in epithelial-mesenchymal-transition (EMT) and metastasis in pancreatic cancer cells to investigate whether eIFs and downstream c-MYC affect EMT and metastasis by joint interference...
December 14, 2021: Cancer Cell International
https://read.qxmd.com/read/34769510/translation-inhibitors-activate-autophagy-master-regulators-tfeb-and-tfe3
#15
JOURNAL ARTICLE
Thao Thi Dang, Sung Hoon Back
The autophagy-lysosome pathway is a major protein degradation pathway stimulated by multiple cellular stresses, including nutrient or growth factor deprivation, hypoxia, misfolded proteins, damaged organelles, and intracellular pathogens. Recent studies have revealed that transcription factor EB (TFEB) and transcription factor E3 (TFE3) play a pivotal role in the biogenesis and functions of autophagosome and lysosome. Here we report that three translation inhibitors (cycloheximide, lactimidomycin, and rocaglamide A) can facilitate the nuclear translocation of TFEB/TFE3 via dephosphorylation and 14-3-3 dissociation...
November 8, 2021: International Journal of Molecular Sciences
https://read.qxmd.com/read/34604034/neurofibromatosis-molecular-pathogenesis-and-natural-compounds-as-potential-treatments
#16
REVIEW
Anusha Amaravathi, Janet L Oblinger, D Bradley Welling, A Douglas Kinghorn, Long-Sheng Chang
The neurofibromatosis syndromes, including NF1, NF2, and schwannomatosis, are tumor suppressor syndromes characterized by multiple nervous system tumors, particularly Schwann cell neoplasms. NF-related tumors are mainly treated by surgery, and some of them have been treated by but are refractory to conventional chemotherapy. Recent advances in molecular genetics and genomics alongside the development of multiple animal models have provided a better understanding of NF tumor biology and facilitated target identification and therapeutic evaluation...
2021: Frontiers in Oncology
https://read.qxmd.com/read/34580273/the-prohibitin-binding-compound-fluorizoline-inhibits-mitophagy-in-cancer-cells
#17
JOURNAL ARTICLE
Sonia Núñez-Vázquez, José Saura-Esteller, Ismael Sánchez-Vera, Emma Guilbaud, Ana M Cosialls, Gabriel Pons, Jean-Ehrland Ricci, Daniel Iglesias-Serret, Sandrine Marchetti, Joan Gil
Fluorizoline is a prohibitin-binding compound that triggers apoptosis in several cell lines from murine and human origin, as well as in primary cells from hematologic malignancies by inducing the integrated stress response and ER stress. Recently, it was described that PHB (Prohibitin) 1 and 2 are crucial mitophagy receptors involved in mediating the autophagic degradation of mitochondria. We measured mitophagy in HeLa cells expressing Parkin and in A549, a lung cancer cell line that can undergo mitophagy in a Parkin-independent manner, and we demonstrated that both fluorizoline and rocaglamide A, another PHB-binding molecule, inhibit CCCP- and OA-induced mitophagy...
September 27, 2021: Oncogenesis
https://read.qxmd.com/read/34398253/targeted-inhibition-of-eif4a-suppresses-b-cell-receptor-induced-translation-and-expression-of-myc-and-mcl1-in-chronic-lymphocytic-leukemia-cells
#18
JOURNAL ARTICLE
Sarah Wilmore, Karly-Rai Rogers-Broadway, Joe Taylor, Elizabeth Lemm, Rachel Fell, Freda K Stevenson, Francesco Forconi, Andrew J Steele, Mark Coldwell, Graham Packham, Alison Yeomans
Signaling via the B-cell receptor (BCR) is a key driver and therapeutic target in chronic lymphocytic leukemia (CLL). BCR stimulation of CLL cells induces expression of eIF4A, an initiation factor important for translation of multiple oncoproteins, and reduces expression of PDCD4, a natural inhibitor of eIF4A, suggesting that eIF4A may be a critical nexus controlling protein expression downstream of the BCR in these cells. We, therefore, investigated the effect of eIF4A inhibitors (eIF4Ai) on BCR-induced responses...
August 16, 2021: Cellular and Molecular Life Sciences: CMLS
https://read.qxmd.com/read/34353608/1-aminomethyl-sar-in-a-novel-series-of-flavagline-inspired-eif4a-inhibitors-effects-of-amine-substitution-on-cell-potency-and-in-vitro-pk-properties
#19
JOURNAL ARTICLE
Christian Nilewski, Theodore D Michels, Garrick K Packard, Alan X Xiang, Paul A Sprengeler, Boreth Eam, Sarah Fish, Peggy A Thompson, Christopher J Wegerski, Andres Nevarez, Jeff Clarine, Samuel Sperry, Justin T Ernst, Siegfried H Reich
Flavaglines such as silvestrol (1) and rocaglamide (2) constitute an interesting class of natural products with promising anticancer activities. Their mode of action is based on inhibition of eukaryotic initiation factor 4A (eIF4A) dependent translation through formation of a stable ternary complex with eIF4A and mRNA, thus blocking ribosome scanning. Herein we describe initial SAR studies in a novel series of 1-aminomethyl substituted flavagline-inspired eIF4A inhibitors. We discovered that a variety of N-substitutions at the 1-aminomethyl group are tolerated, making this position pertinent for property and ADME profile tuning...
September 1, 2021: Bioorganic & Medicinal Chemistry Letters
https://read.qxmd.com/read/34104125/comparative-phytochemistry-of-flavaglines-rocaglamides-a-group-of-highly-bioactive-flavolignans-from-aglaia-species-meliaceae
#20
REVIEW
Harald Greger
Flavaglines are formed by cycloaddition of a flavonoid nucleus with a cinnamic acid moiety representing a typical chemical character of the genus Aglaia of the family Meliaceae. Based on biosynthetic considerations 148 derivatives are grouped together into three skeletal types representing 77 cyclopenta[ b ]benzofurans, 61 cyclopenta[ bc ]benzopyrans, and 10 benzo[ b ]oxepines. Apart from different hydroxy, methoxy, and methylenedioxy groups of the aromatic rings, important structural variation is created by different substitutions and stereochemistries of the central cyclopentane ring...
June 4, 2021: Proceedings of the Phytochemical Society of Europe
keyword
keyword
169806
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.